Page 5 - AnnualReport2022-23
P. 5
PART B: PERFORMANCE INFORMATION PART D: HUMAN RESOURCES MANAGEMENT
PROGRAMME 4: HEALTH SYSTEMS SAMRC ORGANOGRAM 283
STRENGTHENING 160
Executive Management Committee 283
PURPOSE OF THE PROGRAMME 160
UNITS THAT CONSTITUTE THIS PROGRAMME 160
PART E: FINANCIAL INFORMATION
PROGRAMME STRATEGIC OBJECTIVES 160
RESEARCH HIGHLIGHTS UNDER NATURE OF BUSINESS AND PRINCIPAL
THIS PROGRAMME 161 ACTIVITIES 312
PROGRAMME 5: PUBLIC HEALTH INNOVATION 179 REPORT OF THE CHIEF EXECUTIVE
PURPOSE OF THE PROGRAMME 179 OFFICER & PRESIDENT 313
UNITS THAT CONSTITUTE THIS PROGRAMME 179
REPORT OF THE AUDITOR GENERAL
PROGRAMME STRATEGIC OBJECTIVES 179 TO PARLIAMENT ON THE SOUTH AFRICAN
RESEARCH HIGHLIGHTS UNDER MEDICAL RESEARCH COUNCIL 314
THIS PROGRAMME 180
ANNEXURE-AUDITOR GENERAL’S
PROGRAMME 6: BIOMEDICAL RESEARCH 201 RESPONSIBILITY FOR THE AUDIT 317
PURPOSE OF THE PROGRAMME 201 ACCOUNTING AUTHORITY’S
UNITS THAT CONSTITUTE THIS PROGRAMME 201 RESPONSIBILITIES AND APPROVAL 320
PROGRAMME STRATEGIC OBJECTIVES 201
AUDIT COMMITTEE REPORT 321
RESEARCH HIGHLIGHTS UNDER
THIS PROGRAMME 202 STATEMENT OF FINANCIAL POSITION 323
SAMRC COLLABORATING CENTRES STATEMENT OF FINANCIAL PERFORMANCE 324
AND TB REPORT SA 230
STATEMENT OF CHANGES IN NET ASSETS 325
STAKEHOLDER ENGAGEMENTS 233
CASH FLOW STATEMENT 326
Corporate Social Responsibilities and Campaigns 233
Digital Platforms and Services 240 STATEMENT OF COMPARISON OF
BUDGET AND ACTUAL AMOUNTS 327
Accounting Policies 328
PART C: GOVERNANCE
NOTES TO THE ANNUAL FINANCIAL
INTRODUCTION 243 STATEMENTS 357
OUR BOARD 245 DETAILED INCOME STATEMENT 391
ENTERPRISE RISK MANAGEMENT 266
B-BBEE COMPLIANCE PERFORMANCE
INFORMATION 273
PROCUREMENT THROUGH OTHER MEANS 274
OTHER NOTABLE RELATIONSHIPS 275
SAMRC ANNUAL REPOR T 2022-23 3